Signaling pathways
-
BA5594 ADX71743Summary: ADX71743 is a highly selective, non-competitive and blood-brain barrier-crossing metabotropic glutamate receptor 7 negative mutational modulator. - BA5595 VU0469650Summary: VU0469650 is a potent, selective, reverse transmutation modulator of receptors that penetrate the CNS.
- BA5596 AZD6538Summary: AZD6538 is a potent, selective and brain-permeable negative-variance modulator.
- BA5597 VU6001966Summary: VU6001966 is a potent negative-conversion modulator that crosses the blood-brain barrier, with mGlu2 and mGlu3's of 78nM and >30μM, respectively.
- BA5598 EGLUSummary: EGLU ((2S)-α-Ethylglutamicacid; (2S)-α-EGLU) is a potent competitive receptor antagonist.
- BA5599 L-AP3Summary: Metabotropic glutamate receptor antagonists
- BA5600 VU0364289Summary: VU0364289 is a site-bound, highly selective modulator of positive sexual reassignment.
- BA5601 DS-3801bSummary: DS-3801b is a potent non-macrolide agonist.
- BA5602 EM574Summary: EM574 is an agonist effective in the human gastric lumen and rabbit gastrointestinal tract.
- BA5603 FezolinetantSummary: Fezolinetant is a neurokinin-3 receptor antagonist.